Phase II Trial of Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Treatment of Adult Patients (>18 Years) With Lymphohematopoietic Disorders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00587054

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:38.998302+00:00

Published At

2017-03-10T00:00:00+00:00

Record Updated At

2017-03-10

Results Posted At

2017-03-10

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Allogeneic Stem Cell Transplant", "Leukemia", "Non-Hodgkins", "Lymphoblastic Lymphoma", "Myelodysplastic Syndrome", "Paroxysmal Nocturnal Hemoglobinuria (PNH)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2017-03-10"

protocolSection.identificationModule.nctId

"NCT00587054"

protocolSection.identificationModule.officialTitle

"Phase II Trial of Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Treatment of Adult Patients (\u003e18 Years) With Lymphohematopoietic Disorders"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2017-03-10"

Study condition terms

• Allogeneic Stem Cell Transplant (protocolSection.conditionsModule.conditions)
• Leukemia (protocolSection.conditionsModule.conditions)
• Non-Hodgkins (protocolSection.conditionsModule.conditions)
• Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
• Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
• Paroxysmal Nocturnal Hemoglobinuria (PNH) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.